Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

Joyce, David A., Gibbons, Deena P., Green, Patricia, Steer, James H., Feldmann, Marc, Brennan, Fionula M.·1994·European Journal of Immunology

Abstract

The biological activity of the pro‐inflammatory cytokine, tumor necrosis factor (TNF)‐α depends on the level of TNF‐α itself, the expression of the p55 and p75 cell surface receptors for TNF on target cells and the concentrations of the natural inhibitors of TNF‐α, the soluble p55 and p75 TNF receptors (TNF‐R). Interleukin (IL)‐10 and IL‐4 are known to inhibit TNF‐α production by monocytes. We, therefore, investigated the effects of IL‐10 and IL‐4 on the cell surface expression and release of TNF‐R by human monocytes to determine whether these cytokines also indirectly modulated the biological activity of TNF‐α. Exposure to IL‐10 (1‐10 U/ml) for 24 or 48 h increased soluble p75 TNF‐R expression and concomitantly reduced surface expression of p75 TNF‐R. Further, IL‐l α‐stimulated production of TNF‐α was diminished by IL‐10 and only a small proportion of this TNF‐α was bioactive, consistent with increased production of inhibitory soluble TNF‐R. IL‐10 also induced down‐regulation of surface p55 TNF‐R on monocytes, and increased release of soluble p55 TNF‐R. However, the expression of soluble p55 TNF‐R was much lower than soluble p75 TNF‐R, indicating that it contributed less importantly to neutralization of TNF‐α under these conditions. Like IL‐10, IL‐4 supressed the release of TNF‐α by monocytes. In contrast to IL‐10, however, IL‐4 (0.1‐10 ng/ml) supressed the release of soluble p75 TNF‐R from monocytes in a dose‐dependent manner. Release of soluble p55 TNF‐R was also supressed by IL‐4. IL‐10, therefore, reduces the pro‐inflammatory potential of TNF in three ways: by down‐regulating surface TNF‐R expression whilst increasing production of soluble TNF‐R and inhibiting the release of TNF‐α itself. This suggests that IL‐10 may be useful in the treatment of diseases where overexpression of TNF‐α occurs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.1830241119

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 206

Metadata

Authors
Joyce, D. A., Gibbons, D. P., Green, P., Steer, J. H., Feldmann, M., & Brennan, F. M.
Venue
European Journal of Immunology
Publisher
Wiley
Published
1994-11
Volume
24
Issue
11
Pages
2699-2705
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2149805219
Cited by
206
References
1
FWCI
4.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. https://app.cochat.ai/papers/10.1002/eji.1830241119
The paper
Joyce, D. A., Gibbons, D. P., Green, P., Steer, J. H., Feldmann, M., & Brennan, F. M. (1994). Two inhibitors of pro‐inflammatory cytokine release, interleukin‐10 and interleukin‐4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. European Journal of Immunology. https://doi.org/10.1002/eji.1830241119

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.